Latest Breaking News On - Douglas swirsky - Page 1 : comparemela.com

MaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript

MaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Douglas-swirsky
Maher-masoud

MaxCyte, Inc. (NASDAQ:MXCT) Q3 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by, and welcome to MaxCyte’s Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.

Saudi-arabia
Doug-doerfler
Ali-soleymannezhad
Tosoh-bioscience
Dan-arias
Sean-menarguez
Douglas-swirsky
Doug-swirsky
Maxcyte-bioprocessing
Biggest-plumbing-companies
Maxcyte-inc
Nasdaq

MaxCyte, Inc. (NASDAQ:MXCT) Q2 2023 Earnings Call Transcript

Operator: Thank you for standing by, and welcome to MaxCyte s Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

Panmure-gordon
Madeline-mollman
Lyell-immunopharma
Mark-massaro
Doug-doerfler
Steven-mah
Vittoria-biotherapeutics
Vidyun-bais
Douglasj-swirsky
Matt-larew
Jacob-johnson
Douglas-swirsky

MaxCyte installs Douglas Swirsky as its new finance chief

Cell engineering technology company MaxCyte announced the appointment of Douglas Swirsky as its new chief financial officer on Tuesday.

Ron-holtz
Doug-doerfler
Stifel-nicolaus
Douglas-swirsky
Cellectar-biosciences
Kellogg-school-of-management-at-northwestern-university
Boston-university
Morgan-stanley
Rexahn-pharmaceuticals
Legg-mason
Solid-biosciences
Kellogg-school

MaxCyte appoints new chief financial officer, effective immediately

MaxCyte Inc on Tuesday said it appointed Douglas Swirsky as its new chief financial officer, effective immediately. The Maryland, US-based cell-engineering focused company said Swirsky previously. | March 28, 2023

Maryland
United-states
Greg-rosenvinge
Doug-doerfler
Douglas-swirsky
Maxcyte-inc-on
Alliance-news-ltd
Genvec-inc
Rexahn-pharmaceuticals-inc
Alliance-news
Aavantibio-inc
Cyte-inc